The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelical Bar Regulatory News (HLCL)

Share Price Information for Helical Bar (HLCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 209.50
Bid: 210.50
Ask: 214.50
Change: 4.00 (1.95%)
Spread: 4.00 (1.90%)
Open: 210.00
High: 211.00
Low: 206.50
Prev. Close: 205.50
HLCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HELICAL AGREES SALE OF 25 CHARTERHOUSE SQUARE

25 Mar 2024 07:00

RNS Number : 0496I
Helical PLC
25 March 2024
 

 

HELICAL PLC

("Helical" or the "Group")

 

HELICAL AGREES SALE OF 25 CHARTERHOUSE SQUARE

 

Helical plc has exchanged contracts on the sale of the long leasehold interest in 25 Charterhouse Square, London, EC1 to a Real Estate fund managed by global alternative investment manager, Ares Management ("Ares)", for £43.5 million. The disposal price represents a 6.5% discount to the 30 September 2023 book value.

 

Redeveloped by Helical in 2017, 25 Charterhouse Square is located just a minute's walk from the Farringdon East Elizabeth Line entrance, with views overlooking the leafy Charterhouse Square. The six-storey building provides 45,000 sq ft of modern office space and is home to a range of creative occupiers including marketing agency, Anomaly; the FTSE-listed betting and gaming company, Entain; and the communications consultancy, Hudson Sandler. The building is accredited BREEAM Excellent, WiredScore Gold and offers comprehensive end of journey facilities including nine showers, 94 lockers, 90 secure bike racks, a cycle repair station and a drying room.

 

Gerald Kaye, Chief Executive of Helical plc, commented: "25 Charterhouse Square is a great example of how Helical is delivering modern, attractive workplaces while staying true to its sustainability aims. This redevelopment project transformed the existing building and its success in attracting forward-thinking, creative occupiers is testament to its high quality design, accessible location and excellent amenities. We will look to recycle the proceeds from the sale into our development pipeline, which is focussed on delivering 'best-in-class' Central London office schemes."

 

Wilson Lamont, Partner and Co-Head of Ares European Real Estate, said: "We are delighted to work with Helical as we selectively look to invest in the highest quality assets in the centre of Europe's top cities following a period of market correction. With London at the forefront of this correction, we are now seeing attractive value in Zone 1 locations where tenant demand remains robust, and supply of modern, sustainable space is limited."

 

Helical was advised by Ingleby Trice and Clifford Chance and Ares by Appley, TT&G Partners, Squarebrook and DLA.

 

For further information, please contact:

 

Helical plc 020 7629 0113

Gerald Kaye (Chief Executive)

Tim Murphy (CFO)

 

Address: 5 Hanover Square, London W1S 1HQ

Website: www.helical.co.uk

Twitter: @helicalplc

 

FTI Consulting 020 3727 1000

Dido Laurimore/ Richard Gotla

schelical@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISBIGDXRUDDGSD
Date   Source Headline
22nd Apr 20247:00 amRNSTrading Update
4th Apr 202410:00 amRNSListing Rule 9.6.14(2) Disclosure
25th Mar 20247:00 amRNSHELICAL AGREES SALE OF 25 CHARTERHOUSE SQUARE
15th Mar 20247:00 amRNSThree Crowns signs lease at The JJ Mack Building
14th Mar 20244:31 pmRNSDirector/PDMR Shareholding
8th Feb 20249:15 amRNSChanges to Board and Committee Composition
23rd Jan 20243:59 pmRNSDirector/PDMR Shareholding
16th Jan 202411:09 amRNSDirector/PDMR Shareholding
15th Jan 202410:27 amRNSMajor Shareholding Notification
11th Jan 20244:06 pmRNSMajor Shareholding Notification
9th Jan 20247:00 amRNSTrading Update
6th Dec 20238:34 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSSainsbury's signs lease at The JJ Mack Building
30th Nov 20233:57 pmRNSHolding(s) in Company
29th Nov 20232:53 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSHalf-year Report
1st Nov 202312:28 pmRNSWeWork Update
13th Sep 20235:15 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20238:00 amRNSNotice of Results
1st Aug 20237:00 amRNSNotification of Interests of Directors and PDMRs
19th Jul 20232:41 pmRNSHolding(s) in Company
13th Jul 202311:36 amRNSResult of AGM
13th Jul 20237:00 amRNSTrading Update
12th Jul 20237:00 amRNSHelical signs contract for office portfolio JV
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
13th Jun 20237:00 amRNSNotice of AGM & 2023 Annual Report & Accounts
7th Jun 202310:09 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20234:46 pmRNSHolding(s) in Company
23rd May 20237:00 amRNSAnnual Results for the Year to 31 March 2023
27th Apr 202311:27 amRNSHolding(s) in Company
24th Apr 20239:18 amRNSDirector Declaration
6th Apr 20237:00 amRNSTrading Update
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 20238:00 amRNSNotice of Results
15th Mar 20234:05 pmRNSDirector/PDMR Shareholding
2nd Mar 202312:43 pmRNSHolding(s) in Company
15th Feb 202312:07 pmRNSHelical selected as preferred office JV partner
17th Jan 20239:28 amRNSDirector/PDMR Shareholding
7th Dec 20224:35 pmRNSDirector/PDMR Shareholding
29th Nov 20229:28 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
14th Nov 202210:05 amRNSMajor Shareholding Notification
14th Nov 20227:00 amRNSFIRST LETTING AT THE JJ MACK BUILDING
11th Nov 202210:27 amRNSMajor Shareholding Notification
24th Oct 20227:00 amRNSTrading Update
12th Oct 202211:46 amRNSNotification under Listing Rule 9.6.14 (2)
13th Sep 20222:26 pmRNSDirector/PDMR Shareholding
9th Sep 20229:40 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.